Alerts will be sent to your verified email
Verify EmailTRIMURTHI
|
Novelix Pharma
|
Maximus Internatl.
|
Parshva Enterprises
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.0 | 16.91 % | 1.76 % |
|
5yr average Equity Multiplier
|
1.26 | 2.11 | 1.18 |
|
5yr Average Asset Turnover Ratio
|
0.84 | 1.24 | 1.52 |
|
5yr Avg Net Profit Margin
|
-14.11 % | 6.41 % | 0.98 % |
|
Price to Book
|
24.59 | 2.06 | 16.22 |
|
P/E
|
69.37 | 19.32 | 678.0 |
|
5yr Avg Cash Conversion Cycle
|
29.1 Days | 113.58 Days | 103.36 Days |
|
Inventory Days
|
34.04 Days | 26.36 Days | 63.35 Days |
|
Days Receivable
|
55.38 Days | 142.26 Days | 79.86 Days |
|
Days Payable
|
55.7 Days | 59.13 Days | 16.02 Days |
|
5yr Average Interest Coverage Ratio
|
-17.77 | 4.83 | 3.55 |
|
5yr Avg ROCE
|
-15.4 % | 17.67 % | 3.48 % |
|
5yr Avg Operating Profit Margin
|
-16.49 % | 8.97 % | 2.31 % |
|
5 yr average Debt to Equity
|
0.05 | 0.32 | 0.07 |
|
5yr CAGR Net Profit
|
35.78 % | 23.84 % | -1.98 % |
|
5yr Average Return on Assets
|
-13.36 % | 7.99 % | 1.5 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.43 % | 57.58 % | 74.64 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.53 % |
|
Change in Promoter Holding (3 Yrs)
|
-17.49 % | -6.05 % | 0.11 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Novelix Pharma
|
Maximus Internatl.
|
Parshva Enterprises
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|